The KRAS gene mutation, responsible for a quarter of all cancerous tumors, has met its match. Thanks to UCSF research, a tiny ...
In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the ...
The trial at UT Southwestern Medical Center involves an innovative chemotherapy treatment for patients with locally advanced ...
Funding advances Phase 2 expansion cohorts in pancreatic and colorectal cancer in ATM-negative patients for Artios’ potential ...
We urge policymakers and the public to stand together to protect and expand funding for cancer research. Progress is not ...
Pancreatic ductal adenocarcinoma is projected to become the second-leading cause of cancer death in the United States by 2030 ...
Last year, researchers at the University of California, Riverside, developed a novel "molecular crowbar" strategy to degrade ...
A new study from Johns Hopkins Medicine has found that even a small enlargement of the pancreatic duct — the tiny tube that ...
Young cancer, rising health costs, and financial strain are reshaping America's healthcare system as more people under 50 ...
The DESTINY-Breast11 trial showed in patients with high-risk HER2-positive early breast cancer that the ADC followed by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback